As FDA's Peter Marks resigns, industry watchers size up vaccine, cell and gene therapy hits
In resigning as director of the FDA’s Center for Biologics Evaluation and Research, Peter Marks, M.D., Ph.D., blast the promotion of vaccine disinformation under new HHS secretary Robert F. Kennedy Jr.
